AKLIAkili, Inc.

Nasdaq akiliinteractive.com


$ 0.43 $ 0.00 (0.49 %)    

Friday, 21-Jun-2024 15:30:17 EDT
QQQ $ 480.84 $ -1.29 (-0.27 %)
DIA $ 391.56 $ -0.73 (-0.19 %)
SPY $ 544.47 $ -0.73 (-0.13 %)
TLT $ 93.96 $ 0.00 (0 %)
GLD $ 214.79 $ -3.38 (-1.55 %)
$ 0.428
$ 0.42
$ 0.00 x 0
$ 0.00 x 0
$ 0.42 - $ 0.43
$ 0.19 - $ 1.25
150,558
na
33.61M
$ 1.18
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 02-29-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-12-2023 03-31-2023 10-Q
6 03-09-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-12-2022 06-30-2022 10-Q
9 05-16-2022 03-31-2022 10-Q
10 03-23-2022 12-31-2021 10-K
11 11-15-2021 09-30-2021 10-Q
12 08-16-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 akili-says-endeavorotc-is-the-only-fda-authorized-digital-therapeutic-for-adhd-available-without-a-prescription

Delivered through an engaging video game experience, EndeavorOTC is indicated to improve attention function as measured by comp...

 akili-q1-2024-adj-eps-012-beats-014-estimate-sales-38300k-miss-79400k-estimate

Akili (NASDAQ:AKLI) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.14) by 14.2...

 akili-announces-amended-agreement-with-shionogi-shionogi-has-canceled-and-forgiven-a-5m-long-term-debt-obligation-and-agreed-to-make-certain-payments-for-sdt-001-the-japanese-localized-version-of-akilis-akl-t01-digital-treatment-marketed-as-endeavorrx-in-the-us

Shionogi amendment provides Akili with near-term cash payments and cancellation of debt obligationCompany announces exploration...